Industry News

The Vaccines Manufacturing Innovation Centre is planning to create a £66 million research and production facility in the United Kingdom. Located in the Oxford Science Park, the project will support the development and manufacturing of vaccines for clinical trials and epidemic threat mitigation, as well as the creation of gene therapy technologies and personalized medicine solutions.

Children's National Health System broke ground in late November of 2018 on the Research and Innovation Campus in Washington. The project includes the renovation of four existing buildings located on 12 acres on the former Walter Reed Medical Center Campus. A 333,000-sf research and innovation facility will provide 158,000 sf of laboratory space for the study of pediatric genomics and precision medicine. The project will include a business incubator and 175,000 of shell space to accommodate future growth. Completion is expected in 2020.

The Quadram Institute began the phased occupation of its £75 million translational research facility in fall of 2018. Located in the Norwich Research Park in the United Kingdom, the 150,000-sf complex was created by Norfolk & Norwich University Hospital, the University of East Anglia, Quadram Institute Bioscience, and the Biotechnology and Biological Sciences Research Council.

Muskegon Community College opened the $14.1 million Health and Wellness Center in November of 2018 in Muskegon, Mich. Designed by The Collaborative, the 52,000-sf facility provides a 3,000-sf simulation training lab, classrooms, collaborative learning spaces, faculty offices, a multipurpose room, a gymnasium, an indoor track, and a fitness center.

Children's Hospital of Philadelphia completed construction of the $75 million Clinical Vector Core in November of 2018. Located on the basement level of the Colket Translational Research Building, the project provides laboratories, offices, four production suites, and cleanrooms for the manufacture of gene therapy agents for clinical trials. The 15,000-sf facility features robust environmental controls and was built at a cost of $44 million. The Clinical Vector Core is part of the Raymond G.